Obermatt
See Similar Stocks →

eXoZymes

NAQ:EXOZ · US4618741098
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings—
Price/Book3
Dividend Yield1
Revenue Growth—
Profit Growth81
Capital Growth37
TSR 52w15
Leverage20
Liquidity100
Refinancing55
Combined—
Analyst Opinions—
Pro Holdings35
Opinion Changes—
Market Pulse8

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Founded2014
Employees32
Websiteexozymes.com
ISINUS4618741098
Last UpdateApr 2, 2026
Index & Theme
CleanTechBio-based and Renewable MaterialsNutraceuticalGeneticsBiotechnology

Description

eXoZymes, Inc. (eXoZymes) operates as a development stage synthetic biochemical company. The company has developed unique technology that will allow it to harness more of the mechanisms nature uses for biochemical production. The company foresees th…

Similar Stocks

The companies this stock is ranked against.

Compare eXoZymes with its peers
Recursion Pharmaceuticals
NSQ:RXRX
20
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Actuate Therapeutics
NMQ:ACTU
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Metagenomi Therapeutics
NSQ:MGX
24
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Mineralys Therapeutics
NSQ:MLYS
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Ambarella
NSQ:AMBA
19
CountryUSA
IndustrySemiconductors & Semiconductor Equipment
SizeMedium
Full Stock Analysis →
Corvus Pharmaceuticals
NMQ:CRVS
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →